Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Heather Stahl

Physician Assistant Johnstown, PA Physician Assistant

NPI 1609494103 CMS profile 10434814

1 Tech Park Dr, Johnstown, PA 15901

Open in the dashboard

General payments

$7,410

305 records reported · program years 2021–2025

Research payments

$700

Paid to them · 4 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heather Stahl of Johnstown, PA is reported in the CMS Open Payments database as having received $7,410 across 305 general payments and $700 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,751 84
2024 General $1,192 47
2023 General $931 33
2023 Research $700 4
2022 General $1,806 101
2021 General $729 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Stahl
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Heather Stahl were reported at $2,751. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Heather Stahl Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $729 $132 $37–$438 $132
2022 $1,806 $155 $48–$522 $149
2023 $931 $167 $52–$557 $160
2024 $1,192 $178 $55–$600 $164
2025 $2,751 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Inari Medical, Inc. $1,289 21 payments
  2. Stryker Corporation $1,141 30 payments
  3. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,012 56 payments
  4. Janssen Pharmaceuticals, Inc $775 42 payments
  5. Novartis Pharmaceuticals Corporation $352 18 payments
  6. Pfizer Inc. $334 20 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $304 17 payments
  8. Boston Scientific Corporation $265 10 payments
  9. Merck Sharp & Dohme Corporation $239 14 payments
  10. Actelion Pharmaceuticals US, Inc. $233 7 payments
  11. Other $1,466 70 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,661 303 payments
  2. Travel and Lodging $649 1 payment
  3. Education $100 1 payment
Products named General payments · program years 2021–2025
  1. CT THROMBECTOMY SYSTEM KIT $2,190 39 payments
  2. FLOWTRIEVER CATHETER, S $2,190 39 payments
  3. LifeVest $1,012 56 payments
  4. XARELTO $775 42 payments
  5. ELIQUIS $296 18 payments
  6. JARDIANCE $263 15 payments
  7. VERQUVO $239 14 payments
  8. LEQVIO $239 11 payments
  9. OPSUMIT $233 7 payments
  10. FLOWTRIEVER $232 11 payments
  11. Other $2,391 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $700 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

817

Median for Physician Assistant: 241

Drug cost

$97,859

Median for Physician Assistant: $4,110

Branded share of claims

33.8%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 46 $45,647
Entresto Sacubitril/Valsartan Brand 41 $31,416
Jardiance Empagliflozin Brand 13 $12,710
Metoprolol Succinate Generic 91 $1,404
Atorvastatin Calcium Generic 66 $822
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 45 $766
Clopidogrel Clopidogrel Bisulfate Brand 46 $669
Ranolazine Er Ranolazine Brand 11 $639
Rosuvastatin Calcium Generic 36 $440
Captopril Generic 13 $427

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$15,992

Medicare's payments for the services billed

Medicare patients

160

Average age 76

Services billed

269

61 women, 99 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 72%
Arthritis 59%
Heart failure 58%
Chronic kidney disease 56%
Diabetes 49%
Atrial fibrillation 49%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $122
$122 — —
Arcalyst
  • Kiniksa Pharmaceuticals International, plc $53
$53 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $47
$47 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $30
$30 — —
OPSUMIT
  • Actelion Pharmaceuticals US, Inc. $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

309 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record